drugset / Trial / NCT02947191

Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation

NCT02947191

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of collagen membrane combined with human clinical grade umbilical cord mesenchymal stem cells(HUC-MSCs) transplantation in patients with chronic nasal septum perforation.

Timeline

Start
2016-11
Primary completion
2021-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject human umbilical cord mesenchymal stem cells Cell therapy

Indications